Pharmalot By Ed Silverman Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds
Pharmalot By Ed Silverman High blood pressure pills are costly — but also hard to find — in some lower-income countries
Health By Lauran Neergaard — Associated Press FDA clears Covid booster shot for healthy kids ages 5 to 11
Health By Usha Lee McFarling National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials
D.C. Diagnosis By Nicholas Florko As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
Pharmalot By Ed Silverman Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver
First Opinion By Danielle Wenner and Gabriela Arguedas Ramírez Omitting long Covid from pandemic messaging is harmful for public health
First Opinion By Joe Lieberman and Michelle McMurry-Heath Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures
Health By Melissa Bailey We used to sell cigarettes in hospitals. 5 practices that may soon look just as outdated
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Express Scripts criticized for not disclosing info about key committee
First Opinion By Tejal K. Gandhi and Patricia A. McGaffigan Working to exhaustion: How medical residents’ long shifts put patients at risk
Pharmalot By Ed Silverman After French tragedy, European authorities to review guidelines for clinical trials
Health By Melissa Bailey Communication failures linked to 1,744 deaths in five years, US malpractice study finds